RXST RxSight Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RXST

Price (delayed)

$61.735

Market cap

$2.28B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.41

Enterprise value

$2.28B

Highlights
RXST's gross profit has soared by 152% YoY and by 24% from the previous quarter
RxSight's debt has plunged by 93% YoY and by 10% from the previous quarter
RxSight's quick ratio has decreased by 9% from the previous quarter but it has increased by 4% YoY
Sector: Healthcare
Industry: Medical Devices

Key stats

What are the main financial stats of RXST
Market
Shares outstanding
36.99M
Market cap
$2.28B
Enterprise value
$2.28B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.81
Price to sales (P/S)
23.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
25.55
Earnings
Revenue
$89.08M
EBIT
-$45.28M
EBITDA
-$41.04M
Free cash flow
-$46.41M
Per share
EPS
-$1.41
Free cash flow per share
-$1.35
Book value per share
$4.47
Revenue per share
$2.59
TBVPS
$5.3
Balance sheet
Total assets
$182.55M
Total liabilities
$22.19M
Debt
$3.01M
Equity
$160.36M
Working capital
$147.5M
Liquidity
Debt to equity
0.02
Current ratio
8.06
Quick ratio
7.09
Net debt/EBITDA
0.18
Margins
EBITDA margin
-46.1%
Gross margin
60.4%
Net margin
-54.6%
Operating margin
-56.2%
Efficiency
Return on assets
-25.5%
Return on equity
-31.2%
Return on invested capital
-25.1%
Return on capital employed
-28%
Return on sales
-50.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RXST stock price

How has the RxSight stock price performed over time
Intraday
3.53%
1 week
16.99%
1 month
20.48%
1 year
227.51%
YTD
53.11%
QTD
19.69%

Financial performance

How have RxSight's revenue and profit performed over time
Revenue
$89.08M
Gross profit
$53.77M
Operating income
-$50.09M
Net income
-$48.61M
Gross margin
60.4%
Net margin
-54.6%
RXST's gross profit has soared by 152% YoY and by 24% from the previous quarter
RXST's revenue has surged by 82% year-on-year and by 16% since the previous quarter
RxSight's net margin has soared by 60% YoY and by 24% from the previous quarter
The company's operating margin has surged by 57% YoY and by 21% QoQ

Growth

What is RxSight's growth rate over time

Valuation

What is RxSight stock price valuation
P/E
N/A
P/B
13.81
P/S
23.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
25.55
The EPS has grown by 41% year-on-year and by 18% since the previous quarter
RXST's P/B is 112% above its last 4 quarters average of 6.3
RXST's equity has surged by 78% year-on-year
RXST's revenue has surged by 82% year-on-year and by 16% since the previous quarter
RXST's P/S is 76% above its last 4 quarters average of 13.1

Efficiency

How efficient is RxSight business performance
The return on sales has surged by 60% year-on-year and by 23% since the previous quarter
RXST's ROE has soared by 51% YoY and by 22% QoQ
The ROA has increased by 38% YoY and by 16% from the previous quarter
RxSight's return on invested capital has increased by 29% YoY and by 8% QoQ

Dividends

What is RXST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RXST.

Financial health

How did RxSight financials performed over time
The company's total liabilities has shrunk by 63% YoY but it rose by 9% QoQ
The total assets has grown by 22% year-on-year
RxSight's debt is 98% less than its equity
RXST's debt to equity has dropped by 96% year-on-year
RxSight's debt has plunged by 93% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.